4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-3-methoxy-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid ethyl ester

ID: ALA160384

PubChem CID: 10787834

Max Phase: Preclinical

Molecular Formula: C22H28N4O4

Molecular Weight: 412.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1cc2c(c(CCn3cnc4c3NC=NCC4O)c1OC)CCCC2

Standard InChI:  InChI=1S/C22H28N4O4/c1-3-30-22(28)17-10-14-6-4-5-7-15(14)16(20(17)29-2)8-9-26-13-25-19-18(27)11-23-12-24-21(19)26/h10,12-13,18,27H,3-9,11H2,1-2H3,(H,23,24)

Standard InChI Key:  CDRWHDFUDSLBOV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    3.0542   -1.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4917   -1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2917   -0.9000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6292   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0167   -1.5542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1167   -1.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4542   -2.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5875   -1.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8917   -0.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6292   -2.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5875   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1542   -1.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1042   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4667   -1.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0667   -1.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9625   -2.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5417   -1.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -2.6250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1750   -0.9750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1042   -0.9625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6792   -1.8917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167   -1.0417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0542   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1042   -3.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6750   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5875   -0.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0542   -3.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5750   -3.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2000   -2.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  6  2  0
  5  2  1  0
  6  8  1  0
  7  2  1  0
  8 15  1  0
  9  3  2  0
 10 13  2  0
 11  8  2  0
 12  4  1  0
 13 11  1  0
 14  1  1  0
 15 17  1  0
 16  7  1  0
 17  5  1  0
 18 23  1  0
 19 12  2  0
 20  6  1  0
 21 12  1  0
 22 14  1  0
 23 14  1  0
 24 11  1  0
 25 13  1  0
 26 21  1  0
 27 20  1  0
 28 24  1  0
 29 28  1  0
 30 26  1  0
  9  5  1  0
 16 18  2  0
  4 10  1  0
 25 29  1  0
M  END

Associated Targets(Human)

AMPD3 Tchem AMP deaminase 3 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADA Adenosine deaminase (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 412.49Molecular Weight (Monoisotopic): 412.2111AlogP: 2.68#Rotatable Bonds: 6
Polar Surface Area: 97.97Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.06CX Basic pKa: 6.50CX LogP: 2.62CX LogD: 2.57
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.71Np Likeness Score: -0.04

References

1. Kasibhatla SR, Bookser BC, Xiao W, Erion MD..  (2001)  AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.,  44  (4): [PMID:11170651] [10.1021/jm000355t]

Source